BMS-936557
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS-936557, covering 2015-06-25 to 2015-10-12. Get the full timeline:
Most recent: Clinical Trial Update: Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease [Phase 2]